Does the Use of Chitosan Contribute to Oxalate Kidney Stone Formation?

被引:904
作者
Queiroz, Moacir Fernandes [1 ]
Teodosio Melo, Karoline Rachel [1 ]
Sabry, Diego Araujo [2 ,3 ]
Sassaki, Guilherme Lanzi [2 ]
Oliveira Rocha, Hugo Alexandre [1 ]
机构
[1] Univ Fed Rio Grande do Norte, Biosci Ctr, Dept Biochem, BR-59078970 Natal, RN, Brazil
[2] Univ Fed Parana, Ctr Biol Sci, Dept Biochem, BR-19031 Curitiba, PR, Brazil
[3] Univ Fed Sao Paulo, Dept Biochem, BR-04044020 Sao Paulo, Brazil
关键词
urolithiasis; antioxidant activity; calcium oxalate monohydrate crystals; copper chelation; SULFATED POLYSACCHARIDES; BIOMEDICAL APPLICATIONS; ANTIMICROBIAL ACTIVITY; LIPID-PEROXIDATION; MOLECULAR-WEIGHT; ANTIOXIDANT; ANTICOAGULANT; SUPPLEMENTATION; CRYSTAL;
D O I
10.3390/md13010141
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Chitosan is widely used in the biomedical field due its chemical and pharmacological properties. However, intake of chitosan results in renal tissue accumulation of chitosan and promotes an increase in calcium excretion. On the other hand, the effect of chitosan on the formation of calcium oxalate crystals (CaOx) has not been described. In this work, we evaluated the antioxidant capacity of chitosan and its interference in the formation of CaOx crystals in vitro. Here, the chitosan obtained commercially had its identity confirmed by nuclear magnetic resonance and infrared spectroscopy. In several tests, this chitosan showed low or no antioxidant activity. However, it also showed excellent copper-chelating activity. In vitro, chitosan acted as an inducer mainly of monohydrate CaOx crystal formation, which is more prevalent in patients with urolithiasis. We also observed that chitosan modifies the morphology and size of these crystals, as well as changes the surface charge of the crystals, making them even more positive, which can facilitate the interaction of these crystals with renal cells. Chitosan greatly influences the formation of crystals in vitro, and in vivo analyses should be conducted to assess the risk of using chitosan.
引用
收藏
页码:141 / 158
页数:18
相关论文
共 48 条
[1]  
Anbazhagan M, 1999, J CLIN BIOCHEM NUTR, V27, P37, DOI 10.3164/jcbn.27.37
[2]   COLORIMETRIC ESTIMATION OF ALUMINUM WITH PYROCATECHOL VIOLET [J].
ANTON, A .
ANALYTICAL CHEMISTRY, 1960, 32 (06) :725-726
[3]   The safety of chitosan as a pharmaceutical excipient [J].
Baldrick, Paul .
REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2010, 56 (03) :290-299
[4]   Aggregation-based crystal growth and microstructure development in natural iron oxyhydroxide biomineralization products [J].
Banfield, JF ;
Welch, SA ;
Zhang, HZ ;
Ebert, TT ;
Penn, RL .
SCIENCE, 2000, 289 (5480) :751-754
[5]   Biomedical applications of amino acid-modified chitosans: A review [J].
Casettari, Luca ;
Vllasaliu, Driton ;
Lam, Jenny K. W. ;
Soliman, Mahrrioud ;
Illum, Lisbeth .
BIOMATERIALS, 2012, 33 (30) :7565-7583
[6]  
Chien P.-J., 2007, FOOD CHEM, V155, P221
[7]   Biological activities of sulfated polysaccharides from tropical seaweeds [J].
Costa, L. S. ;
Fidelis, G. P. ;
Cordeiro, S. L. ;
Oliveira, R. M. ;
Sabry, D. A. ;
Camara, R. B. G. ;
Nobre, L. T. D. B. ;
Costa, M. S. S. P. ;
Almeida-Lima, J. ;
Farias, E. H. C. ;
Leite, E. L. ;
Rocha, H. A. O. .
BIOMEDICINE & PHARMACOTHERAPY, 2010, 64 (01) :21-28
[8]   Beneficial effects of tempol, a membrane-permeable radical scavenger, on the multiple organ failure induced by zymosan in the rat [J].
Cuzzocrea, S ;
McDonald, MC ;
Mazzon, E ;
Filipe, HM ;
Centorrino, T ;
Lepore, V ;
Terranova, ML ;
Ciccolo, A ;
Caputi, AP ;
Thiemermann, C .
CRITICAL CARE MEDICINE, 2001, 29 (01) :102-111
[9]  
Czechowska-Biskup R, 2012, PROG CHEM APPL CHITI, V17, P5
[10]   Oxidative Renal Cell Injury Induced by Calcium Oxalate Crystal and Renoprotection with Antioxidants: A Possible Role of Oxidative Stress in Nephrolithiasis [J].
Davalos, Mauricio ;
Konno, Sensuke ;
Eshghi, Majid ;
Choudhury, Muhammad .
JOURNAL OF ENDOUROLOGY, 2010, 24 (03) :339-345